Three mutations, namely, JAK2V617F, MPL, and CALR, were simultaneously screened in a cohort of 668 Chinese patients with confirmed PV (N = 128), ET (N = 407), and PMF (N = 133) from our center to estimate CALR mutation profile in Chinese patients with MPN. Here, CALR is linked to myeloproliferative disorder.